Hormone therapy slows or stops the growth of hormone-sensitive breast cancer.
About 70 – 80 percent of breast cancer are stimulated by the hormones oestrogen and progesterone. These breast cancer cells have proteins called hormone receptors. The receptors are activated when oestrogen and progesterone attach to them, which causes the cells to grow and divide.
Hormone therapy blocks hormones from attaching to the receptors on cancer cells or reduces the body’s production of hormones.
Your doctor may use different approaches to treat your breast cancer using hormone therapy. These include:
Preventing hormones from attaching to cancer cells slows down the growth of the cancer. The cancerous cells may eventually die.
Aromatase inhibitors are a class of medicines that reduce the amount of oestrogen in your body. This deprives cancer cells of the hormones they need to grow.
This therapy is only for women who have undergone menopause or have had their ovaries removed.
Women who are pre-menopausal may undergo treatments to stop their ovaries from producing hormones.
These include:
Stopping your ovarian functions allows you to take hormone therapy medications meant for women who have undergone menopause.
This treatment option applies to hormone-sensitive breast cancer that has spread to other parts of the body.
Targeted therapy attacks specific pathways that drive breast cancer cell growth. Combining targeted and hormonal therapies can make the treatment more effective.
Hormone therapy for breast cancer can:
The side effects of hormone therapy for breast cancer depend on the type of treatment and medications used. Common side effects include:
Some patients may experience more serious side effects such as:
For appointment bookings, please Whatsapp
+65 8198 7777
For clinic or corporate matters, please call
+65 6227 7777